DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies

We have previously shown that a specific promyelocytic leukemia-retinoic acid receptor alpha (PML-RARA) DNA vaccine combined with all-trans retinoic acid (ATRA) increases the number of long term survivors with enhanced immune responses in a mouse model of acute promyelocytic leukemia (APL). This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Pogam, Carole, Patel, Satyananda, Gorombei, Petra, Guerenne, Laura, Krief, Patricia, Omidvar, Nader, Tekin, Nilgun, Bernasconi, Elena, Sicre, Flore, Schlageter, Marie-Helene, Chopin, Martine, Noguera, Maria-Elena, West, Robert, Abu, Ansu, Mathews, Vikram, Pla, Marika, Fenaux, Pierre, Chomienne, Christine, Padua, Rose Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper: Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741708/
https://www.ncbi.nlm.nih.gov/pubmed/26378812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741708/
https://www.ncbi.nlm.nih.gov/pubmed/26378812

Ejemplares similares